Cliff Asness's LFCR Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 16,171 shares of Lifecore Biomedical, Inc. (LFCR) worth $132,278, representing 0.00% of the portfolio. First purchased in 2020-Q3, this medium-term investment has been held for 12 quarters.
Based on 13F filings, Cliff Asness has maintained a strategic position in LFCR, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2021, adding 61,481 shares. Largest reduction occurred in Q2 2022, reducing 29,093 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Lifecore Biomedical (LFCR) Holding Value Over Time
Track share changes against reported price movement
Quarterly Lifecore Biomedical (LFCR) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +3,574 | Add 28.37% | 16,171 | $8.18 |
| Q3 2025 | +1,146 | Add 10.01% | 12,597 | $7.36 |
| Q2 2025 | +11,451 | New Buy | 11,451 | $8.12 |
| Q3 2022 | -21,782 | Sold Out | 0 | $0.00 |
| Q2 2022 | -29,093 | Reduce 57.19% | 21,782 | $9.96 |
| Q1 2022 | -10,108 | Reduce 16.58% | 50,875 | $11.58 |
| Q4 2021 | +1,379 | Add 2.31% | 60,983 | $11.10 |
| Q3 2021 | +3,073 | Add 5.44% | 59,604 | $9.23 |
| Q2 2021 | -4,950 | Reduce 8.05% | 56,531 | $11.25 |
| Q1 2021 | +61,481 | New Buy | 61,481 | $10.60 |
| Q4 2020 | -20,658 | Sold Out | 0 | $0.00 |
| Q3 2020 | +20,658 | New Buy | 20,658 | $9.73 |
Cliff Asness's Lifecore Biomedical Investment FAQs
Cliff Asness first purchased Lifecore Biomedical, Inc. (LFCR) in Q3 2020, acquiring 20,658 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Lifecore Biomedical, Inc. (LFCR) for 12 quarters since Q3 2020.
Cliff Asness's largest addition to Lifecore Biomedical, Inc. (LFCR) was in Q1 2021, adding 61,481 shares worth $652,000.
According to the latest 13F filing for Q4 2025, Cliff Asness's firm, Aqr Capital Management LLC, owns 16,171 shares of Lifecore Biomedical, Inc. (LFCR), valued at approximately $132,278.
As of the Q4 2025 filing, Lifecore Biomedical, Inc. (LFCR) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Lifecore Biomedical, Inc. (LFCR) was 61,481 shares, as reported at the end of Q1 2021.